Imperial Oil Limited Common Stock vs 22nd Century Group Inc — how do they compare? Imperial Oil Limited Common Stock trades at $129.6 (market cap $62.22B), while 22nd Century Group Inc trades at $0.65 (market cap $475.95K). The key difference: Imperial Oil Limited Common Stock is far larger — about 130728× 22nd Century Group Inc's market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| IMO | XXII | |
|---|---|---|
Market Cap | $62.22B | $475.95K |
Volume | 560,544 | 78,911 |
Sector | Energy | Consumer Staples |
52-Week High | $138.33 | $483.00 |
52-Week Low | $83.72 | $0.65 |
Enterprise Value | $63.13B | -$3.83M |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 33 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XXII trades at $0.67, down 7.98% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.06 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives in France and Europe.
Despite analyst optimism (75% buy ratings with $1,240 price target), fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces significant execution risk in commercializing reduced-nicotine tobacco products while navigating regulatory timelines.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →